Biotech Startups

Emerald Cloud Lab (ECL) operates a remotely accessible laboratory system that lets scientists design and run experiments without manual bench work, aiming to shift their focus to orchestrating science. It serves researchers in pharmaceutical research, materials science, medical diagnostics, and agriculture.

8 investors

Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr. Tejal Desai's laboratory at UCSF that combines micro and nanotechnologies with novel drug delivery approaches. The company focuses on therapeutic delivery platforms and cell-based treatments, particularly for diseases including diabetes and autoimmune conditions.

8 investors

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders. Founded in 2019, it focuses on the neuroscience area to treat central nervous system conditions.

8 investors

Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases. The company applies pharmaceutical-industry drug discovery methods to agriculture, enabling faster development of new active ingredients with reduced environmental impact.

8 investors

Entocycle builds automated, vertically farmed insect production systems to make insect protein at industrial scale. The protein serves as an alternative to soymeal and fishmeal for farmers raising fish and free-range poultry.

8 investors

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

8 investors

Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules. Its lead candidate, MOv18 IgE, targets folate receptor alpha and is in clinical development for ovarian cancer.

8 investors

Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.

8 investors

Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.

8 investors

Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway. Its lead candidate, PIKTOR, is an all-oral combination targeting PI3K-alpha, mTORC1, and mTORC2 for cancers including endometrial and HR+/HER2- breast cancer.

8 investors

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

8 investors

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells. A spin-out of the Centre for Probe Development and Commercialization, it focuses on radiopharmaceuticals for cancer treatment.

8 investors

Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.

8 investors

GEn1E Lifesciences is a clinical-stage drug development company that uses an AI platform to design immunomodulatory therapies for rare and inflammatory diseases that lack effective treatments. Its pipeline includes 21+ immunomodulators, with a lead program targeting ARDS.

8 investors

General Proximity develops proximity-based technologies for drug discovery and development. The company employs scientists from leading academic and pharmaceutical institutions.

8 investors

Gordian Biotechnology develops therapies aimed at treating age-related diseases to extend healthy lifespan. It operates in the biotechnology and longevity space.

8 investors

GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.

8 investors

8 investors

HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies. The company serves patients requiring advanced therapeutic interventions.

8 investors

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms. It focuses on antibody and antibody-drug conjugate modalities to treat oncology patients.

8 investors

Ignota Labs uses SAFEPATH, a proprietary AI platform combining machine learning with bioinformatics and cheminformatics data, to identify and resolve drug safety and toxicity problems. It focuses on drugs that failed in preclinical, Phase 1, or Phase 2 clinical trials due to safety issues, aiming to turn them around and bring them to patients faster.

8 investors

Immunai develops AMICA, a data platform for decoding the immune system to accelerate drug discovery and development. The company serves pharmaceutical and biotech researchers working on inflammatory and oncological therapies.

8 investors

Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.

8 investors

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

8 investors